Trident Lifeline Peer Comparison

BSE: 543616

₹421.00

₹-7.15 (-1.67%)

As on 13-Nov-2026IST

Market cap

₹504 Cr

Revenue (TTM)

₹129 Cr

P/E Ratio

26.5

P/B Ratio

4.7

Div. Yield

0 %

Edit

	Trident Lifeline	Shilpa Medicare	Eris Lifesciences	Caplin Point Lab	Pfizer
Market cap (₹ Cr)	504	19,423	18,167	18,140	17,604
Revenue (₹ Cr)	129	1,842	3,330	2,383	2,654
Net Profit (₹ Cr)	19.32	308.62	720.77	700.18	859.38
Net Margin (%)	13.85	16.63	21.60	27.87	30.42
RoE (%)	24.83	11.81	18.93	18.40	18.58
Price to Earnings	26.49	58.43	25.68	26.33	20.48
Price-To-Book	4.67	7.04	4.38	4.65	4.01

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Trident Lifeline	Shilpa Medicare	Eris Lifesciences	Caplin Point Lab	Pfizer
Operating Revenue	129.02	1,538.87	3,129.42	2,187.19	2,519.65
Total Income	139.47	1,602.52	3,147.87	2,302.73	2,707.60
Total Expenditure	100.89	1,157.98	2,020.01	1,426.34	1,615.47
EBITDA	28.13	380.89	1,109.41	760.85	904.18
Depreciation	6.07	119.72	279.50	72.77	57.73
EBIT	22.07	261.17	829.91	688.08	846.45
Interest	5.32	58.79	192.67	0.87	9.57
Other Income	10.45	63.65	18.45	115.54	187.95
Exceptional Items	--	12.16	-17.24	--	-49.16
Profit before Tax	27.19	295.31	638.54	802.79	975.67
Provision for Tax	7.87	51.98	-8.97	153.06	253.24
Profit after Tax	19.32	243.33	647.51	649.73	722.43

Liabilities (₹ Cr)

	Trident Lifeline	Shilpa Medicare	Eris Lifesciences	Caplin Point Lab	Pfizer
Shareholder's Funds	100.40	2,591.20	3,902.67	3,586.42	4,202.90
Minority Interest	7.49	--	-7.01	44.38	--
Non-Current Liabilities	38.07	249.46	1,149.84	20.75	19.19
Current Liabilities	88.16	848.06	2,201.22	385.96	627.48
Total Liabilities	236.16	3,705.61	7,246.72	4,037.51	4,921.88

Assets (₹ Cr)

	Trident Lifeline	Shilpa Medicare	Eris Lifesciences	Caplin Point Lab	Pfizer
Non-Current Assets	91.44	2,578.95	5,582.75	1,451.85	1,046.35
Current Assets	139.79	1,109.77	1,663.97	2,585.66	3,803.22
Total Assets	236.16	3,705.61	7,246.72	4,037.51	4,921.88
Total Debt*	72.99	657.97	2,309.68	0.57	2.50
Net Current Assets	51.62	261.71	-537.25	2,199.70	3,175.74
Contingent Liabilities	5.00	160.01	51.57	17.53	370.49

Cashflow (₹ Cr)

	Trident Lifeline	Shilpa Medicare	Eris Lifesciences	Caplin Point Lab	Pfizer
Cash From Operating Activities	4.69	342.18	537.99	523.24	967.57
Cash Flow from Investing Activities	-36.61	-325.92	-369.46	-582.30	-561.67
Cash from Financing Activities	33.68	13.62	-313.53	-46.46	-798.31
Net Cash Inflow / Outflow	1.76	29.88	-145.00	-105.52	-392.41

Ratios

Profitability Ratios

	Trident Lifeline	Shilpa Medicare	Eris Lifesciences	Caplin Point Lab	Pfizer
ROCE (%)	22.71	11.43	14.47	24.97	23.39
ROE (%)	24.83	9.82	19.23	20.79	17.16
ROA (%)	9.92	6.97	9.18	17.94	14.91
EBIT Margin (%)	29.90	28.89	36.04	40.07	43.34
Net Margin (%)	13.85	15.18	20.57	28.22	26.68
Cash Profit Margin (%)	19.68	23.59	28.49	33.03	29.72

Growth Ratios

	Trident Lifeline	Shilpa Medicare	Eris Lifesciences	Caplin Point Lab	Pfizer
Revenue Growth (%)	48.36	19.62	8.15	12.89	10.45
EBIT Growth (%)	65.96	29.72	8.91	17.90	19.68
Net Profit Growth (%)	84.08	210.81	72.82	20.08	-5.88
EPS Growth (%)	56.19	210.80	73.16	19.57	-5.88
Book Value Growth (%)	51.69	9.67	36.71	26.75	-0.34

Valuation Ratios

	Trident Lifeline	Shilpa Medicare	Eris Lifesciences	Caplin Point Lab	Pfizer
Price / Earnings	16.82	28.03	29.02	17.84	29.89
Price / Book Value	3.41	2.63	4.62	3.27	5.14
Dividend Yield (%)	0.00	0.17	0.00	0.53	1.59
EV/EBITDA	10.08	16.72	17.93	12.43	16.93
Market Cap (₹ Cr)	320.22	6,819.66	17,980.08	11,439.22	21,592.90

Solvency Ratios

	Trident Lifeline	Shilpa Medicare	Eris Lifesciences	Caplin Point Lab	Pfizer
Debt to Equity	0.78	0.25	0.59	0.00	0.00
Short term debt to equity ratio	0.26	0.16	0.12	0.00	0.00
Current Ratio	1.59	1.31	0.76	6.70	6.06
Quick Ratio	1.17	0.88	0.56	5.59	5.31
Interest Coverage	6.11	6.02	4.31	923.75	102.95

Operating Efficiency Ratios

	Trident Lifeline	Shilpa Medicare	Eris Lifesciences	Caplin Point Lab	Pfizer
Debtors to sales (%)	57.09	33.72	21.74	37.76	7.22
Asset Turnover	0.66	0.44	0.46	0.60	0.54
Receivable days	143.34	113.81	63.88	121.68	26.06
Inventory Days	91.49	84.76	43.27	63.83	65.95
Payable days	140.24	101.94	151.85	108.28	81.01
Cash Conversion Cycle	94.59	96.62	-44.70	77.23	11.00